Investor Relations2019-08-30T10:10:33+00:00

Company Mission

Our mission is to make a difference in time by striving to improve outcomes for potential lung cancer patients through early predictive technologies; provide cost savings to patients, payers, and providers; and to provide a fair return on investment to shareholders and other stakeholders.

ProLung is committed to making a positive and significant impact on the healthcare community and to being socially responsible in all its endeavors.

Investor Resources

Investor Toolkit
Investor FAQ
Information Request
Email Alerts
IR Request

Financial Information

SEC Filings
Financial Reports

News & Events

Press Releases
Investor Calendar

Executive Team and Board of Directors

Meet the Team and Board of Directors

Corporate Governance

Governance Highlights
Committee Composition